Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Ekso Bionics Holdings Inc EKSO

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a... see more

Recent & Breaking News (NDAQ:EKSO)

Ekso Bionics® Receives FDA Clearance to Market its EksoNR(TM) Robotic Exoskeleton for Use with Acquired Brain Injury Patients

GlobeNewswire June 25, 2020

Ekso Bionics Announces Closing of $7.89 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire June 10, 2020

Ekso Bionics Announces $7.89 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire June 8, 2020

Ekso Bionics® Named "Best Healthcare Robotics Company" in 2020 MedTech Breakthrough Awards Program

GlobeNewswire June 3, 2020

Ekso Bionics Announces CFIUS Determination Regarding China Joint Venture

GlobeNewswire May 20, 2020

Ekso Bionics Reports First Quarter 2020 Results

GlobeNewswire April 30, 2020

Ekso Bionics® to Report First Quarter 2020 Financial Results on April 30, 2020

GlobeNewswire April 23, 2020

Ekso Bionics Provides COVID-19 Business Update and Reports Preliminary First Quarter 2020 Financial Results

GlobeNewswire April 9, 2020

Ekso Bionics® Announces Reverse Stock Split

GlobeNewswire March 24, 2020

Ekso Bionics Reports Fourth Quarter and Year End 2019 Results

GlobeNewswire February 27, 2020

Ekso Bionics® Announces Collaboration with Kindred Healthcare to Pilot EksoNR in Long-Term Acute Care Hospitals

GlobeNewswire February 25, 2020

Ekso Bionics® to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020

GlobeNewswire February 20, 2020

Post Acute Medical (PAM) Accelerates Adoption of Exoskeleton Rehabilitation with Three Additional EksoNR Devices from Ekso Bionics®

GlobeNewswire February 19, 2020

Ekso Bionics® Releases its Upgraded EksoPulse Platform, Advanced Cloud-Based Analytics for Robotic Exoskeleton-Assisted Rehabilitation

GlobeNewswire February 6, 2020

Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2019 Financial Results; Company Achieves Record Fourth Quarter Revenue

GlobeNewswire January 10, 2020

Ekso Bionics Announces Closing of $5.0 Million Registered Direct Offering

GlobeNewswire December 20, 2019

Ekso Bionics® Expands Distribution of the EksoVest to Northern Europe

GlobeNewswire December 20, 2019

Ekso Bionics Announces $5.0 Million Registered Direct Offering

GlobeNewswire December 19, 2019

Ekso Bionics Reports Third Quarter 2019 Results

GlobeNewswire October 30, 2019

Ekso Bionics® to Report Third Quarter 2019 Financial Results on October 30, 2019

GlobeNewswire October 23, 2019